Previous Article | Next Article 
Journal of Virology, December 2005, p. 15567-15572, Vol. 79, No. 24
0022-538X/05/$08.00+0 doi:10.1128/JVI.79.24.15567-15572.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Restriction of Human Immunodeficiency Virus Type 1 by TRIM-CypA Occurs with Rapid Kinetics and Independently of Cytoplasmic Bodies, Ubiquitin, and Proteasome Activity
David Perez-Caballero,
Theodora Hatziioannou,
Fengwen Zhang,
Simone Cowan, and
Paul D. Bieniasz*
Aaron Diamond AIDS Research Center and the Rockefeller University, New York, New York
Received 29 June 2005/
Accepted 21 September 2005
TRIM-CypA is an owl monkey-specific variant of the retrovirus restriction factor TRIM5
. Here, we exploit its modular domain organization and cyclosporine sensitivity to probe the kinetics and mechanism of TRIM5-mediated restriction. Time of addition/withdrawal experiments reveal that inhibition of incoming human immunodeficiency virus type 1 capsids by TRIM-CypA occurs within minutes of their delivery to the target cell cytoplasm. However, while TRIM-CypA restriction is partly dependent on a RING domain, restriction occurs independently of the ubiquitin/proteasome system. Moreover, tagged TRIM-CypA proteins can be fully active as restriction factors without forming cytoplasmic bodies.
* Corresponding author. Mailing address: Aaron Diamond AIDS Research Center, 455 First Avenue, New York, NY 10016. Phone: (212) 448-5070. Fax: (212) 725-1126. E-mail:
pbienias{at}adarc.org.
D.P-C. and T.H. contributed equally to this work.
Journal of Virology, December 2005, p. 15567-15572, Vol. 79, No. 24
0022-538X/05/$08.00+0 doi:10.1128/JVI.79.24.15567-15572.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Sebastian, S., Grutter, C., de Castillia, C. S., Pertel, T., Olivari, S., Grutter, M. G., Luban, J.
(2009). An Invariant Surface Patch on the TRIM5{alpha} PRYSPRY Domain Is Required for Retroviral Restriction but Dispensable for Capsid Binding. J. Virol.
83: 3365-3373
[Abstract]
[Full Text]
-
Qi, M., Yang, R., Aiken, C.
(2008). Cyclophilin A-Dependent Restriction of Human Immunodeficiency Virus Type 1 Capsid Mutants for Infection of Nondividing Cells. J. Virol.
82: 12001-12008
[Abstract]
[Full Text]
-
Li, X., Sodroski, J.
(2008). The TRIM5{alpha} B-Box 2 Domain Promotes Cooperative Binding to the Retroviral Capsid by Mediating Higher-Order Self-Association. J. Virol.
82: 11495-11502
[Abstract]
[Full Text]
-
Galla, M., Schambach, A., Towers, G. J., Baum, C.
(2008). Cellular Restriction of Retrovirus Particle-Mediated mRNA Transfer. J. Virol.
82: 3069-3077
[Abstract]
[Full Text]
-
Virgen, C. A., Kratovac, Z., Bieniasz, P. D., Hatziioannou, T.
(2008). From the Cover: Independent genesis of chimeric TRIM5-cyclophilin proteins in two primate species. Proc. Natl. Acad. Sci. USA
105: 3563-3568
[Abstract]
[Full Text]
-
Anderson, J. L., Campbell, E. M., Figueiredo, A., Hope, T. J.
(2008). Heat Shock Perturbs TRIM5{alpha} Restriction of Human Immunodeficiency Virus Type 1. J. Virol.
82: 2575-2579
[Abstract]
[Full Text]
-
Campbell, E. M., Perez, O., Anderson, J. L., Hope, T. J.
(2008). Visualization of a proteasome-independent intermediate during restriction of HIV-1 by rhesus TRIM5{alpha}. JCB
180: 549-561
[Abstract]
[Full Text]
-
Diaz-Griffero, F., Kar, A., Perron, M., Xiang, S.-H., Javanbakht, H., Li, X., Sodroski, J.
(2007). Modulation of Retroviral Restriction and Proteasome Inhibitor-Resistant Turnover by Changes in the TRIM5{alpha} B-Box 2 Domain. J. Virol.
81: 10362-10378
[Abstract]
[Full Text]
-
Schaller, T., Ylinen, L. M. J., Webb, B. L. J., Singh, S., Towers, G. J.
(2007). Fusion of Cyclophilin A to Fv1 Enables Cyclosporine-Sensitive Restriction of Human and Feline Immunodeficiency Viruses. J. Virol.
81: 10055-10063
[Abstract]
[Full Text]
-
Campbell, E. M., Dodding, M. P., Yap, M. W., Wu, X., Gallois-Montbrun, S., Malim, M. H., Stoye, J. P., Hope, T. J.
(2007). TRIM5{alpha} Cytoplasmic Bodies Are Highly Dynamic Structures. Mol. Biol. Cell
18: 2102-2111
[Abstract]
[Full Text]
-
Perron, M. J., Stremlau, M., Lee, M., Javanbakht, H., Song, B., Sodroski, J.
(2007). The Human TRIM5{alpha} Restriction Factor Mediates Accelerated Uncoating of the N-Tropic Murine Leukemia Virus Capsid. J. Virol.
81: 2138-2148
[Abstract]
[Full Text]
-
Luban, J.
(2007). Cyclophilin A, TRIM5, and Resistance to Human Immunodeficiency Virus Type 1 Infection. J. Virol.
81: 1054-1061
[Full Text]
-
Chatterji, U., Bobardt, M. D., Gaskill, P., Sheeter, D., Fox, H., Gallay, P. A.
(2006). Trim5{alpha} Accelerates Degradation of Cytosolic Capsid Associated with Productive HIV-1 Entry. J. Biol. Chem.
281: 37025-37033
[Abstract]
[Full Text]
-
Agarwal, S., Harada, J., Schreifels, J., Lech, P., Nikolai, B., Yamaguchi, T., Chanda, S. K., Somia, N. V.
(2006). Isolation, characterization, and genetic complementation of a cellular mutant resistant to retroviral infection. Proc. Natl. Acad. Sci. USA
103: 15933-15938
[Abstract]
[Full Text]
-
Anderson, J. L., Campbell, E. M., Wu, X., Vandegraaff, N., Engelman, A., Hope, T. J.
(2006). Proteasome Inhibition Reveals that a Functional Preintegration Complex Intermediate Can Be Generated during Restriction by Diverse TRIM5 Proteins. J. Virol.
80: 9754-9760
[Abstract]
[Full Text]
-
Ylinen, L. M. J., Keckesova, Z., Webb, B. L. J., Gifford, R. J. M., Smith, T. P. L., Towers, G. J.
(2006). Isolation of an Active Lv1 Gene from Cattle Indicates that Tripartite Motif Protein-Mediated Innate Immunity to Retroviral Infection Is Widespread among Mammals.. J. Virol.
80: 7332-7338
[Abstract]
[Full Text]
-
Wu, X., Anderson, J. L., Campbell, E. M., Joseph, A. M., Hope, T. J.
(2006). Proteasome inhibitors uncouple rhesus TRIM5{alpha} restriction of HIV-1 reverse transcription and infection. Proc. Natl. Acad. Sci. USA
103: 7465-7470
[Abstract]
[Full Text]
-
Emerman, M.
(2006). How TRIM5{alpha} defends against retroviral invasions. Proc. Natl. Acad. Sci. USA
103: 5249-5250
[Full Text]
-
Yap, M. W., Dodding, M. P., Stoye, J. P.
(2006). Trim-cyclophilin a fusion proteins can restrict human immunodeficiency virus type 1 infection at two distinct phases in the viral life cycle.. J. Virol.
80: 4061-4067
[Abstract]
[Full Text]